With a federal demo pending, the pharmaceutical big Johnson & Johnson agreed Wednesday to spend two Ohio counties much more than $20 million for its job in the ongoing opioid crisis.

The settlement will come on the heels of a $572 million settlement the company was ordered to shell out New Brunswick, N.J., for marketing opioids in the point out, the Involved Press documented.

The federal lawsuit is scheduled to begin in fewer than three weeks, and four corporations have already settled. But companies are nevertheless going through 2,000 lawsuits for their part in the opioid epidemic.

In the Ohio settlement, Johnson & Johnson’s subsidiary Janssen Pharmaceutical agrees to pay Cuyahoga and Summit counties $10 million without having admitting liability. The settlement also phone calls for the company to fork out $5 million in lawful fees and give $5.4 million to nonprofits that struggle the epidemic in northeastern Ohio, the AP reported.

Drugmakers Endo, Allergan and Mallinckrodt have also settled with these Ohio counties. Purdue Pharma has built a preliminary settlement to go over all its lawsuits, but 50 percent the states associated say they will oppose the settlement in individual bankruptcy court.